In Vitro and In Vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent Protein
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2) , S313-S322
- https://doi.org/10.1086/520590
Abstract
To facilitate an understanding of the molecular aspects of the pathogenesis of Zaire ebolavirus (ZEBOV) infection, we generated 2 different recombinant viruses expressing enhanced green fluorescent protein (eGFP) from additional transcription units inserted at different positions in the virus genome. These viruses showed in vitro phenotypes similar to that of wild-type ZEBOV (wt-ZEBOV) and were stable over multiple passages. Infection with one of the viruses expressing eGFP produced only mild disease in rhesus macaques, demonstrating a marked attenuation in this animal model. However, in mice lacking signal transducer and activator of transcription 1, both viruses expressing eGFP caused lethal cases of disease that were moderately attenuated, compared with that caused by wt-ZEBOV. In mice, viral replication could be easily tracked by the detection of eGFP-positive cells in tissues, by use of flow cytometry. These findings demonstrate that the incorporation of a foreign gene will attenuate ZEBOV in vivo but that these viruses still have potential for in vitro and in vivo research applications.Keywords
This publication has 40 references indexed in Scilit:
- Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Critical for Ebola Virus Replication in Nonhuman PrimatesJournal of Virology, 2007
- Canine Distemper Virus Uses both the Anterograde and the Hematogenous Pathway for NeuroinvasionJournal of Virology, 2006
- Molecular Determinants of Ebola Virus Virulence in MicePLoS Pathogens, 2006
- Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or ReplicationJournal of Virology, 2006
- Receptor (SLAM [CD150]) Recognition and the V Protein Sustain Swift Lymphocyte-Based Invasion of Mucosal Tissue and Lymphatic Organs by a MorbillivirusJournal of Virology, 2006
- Rescue of Recombinant Marburg Virus from cDNA Is Dependent on Nucleocapsid Protein VP30Journal of Virology, 2006
- Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino OligomersPLoS Pathogens, 2006
- Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell CultureJournal of Virology, 2005
- Development of a New Vaccine for the Prevention of Lassa FeverPLoS Medicine, 2005
- Adding Genes to the RNA Genome of Vesicular Stomatitis Virus: Positional Effects on Stability of ExpressionJournal of Virology, 2002